May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Baseline Intraocular Pressure, Visual Function, and Disc Hemorrhage in the Low–Pressure Glaucoma Treatment Study
Author Affiliations & Notes
  • J.M. Liebmann
    Manhattan Eye, Ear, & Throat Hospital and New York University School of Medicine, New York, NY
  • D.S. Greenfield
    Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL
  • J. Piltz–Seymour
    Scheie Eye Institute, Philadelphia, PA
  • R. Ritch
    New York Eye and Ear Infirmary and New York Medical College, New York, NY
  • T. Krupin
    Feinberg School of Medicine, Northwestern University, Chicago, IL
  • Low–pressure Glaucoma Study Group
    Manhattan Eye, Ear, & Throat Hospital and New York University School of Medicine, New York, NY
  • Footnotes
    Commercial Relationships  J.M. Liebmann, None; D.S. Greenfield, None; J. Piltz–Seymour, None; R. Ritch, None; T. Krupin, None.
  • Footnotes
    Support  Supported by an unrestricted grant to the LoGTS Group from Allergan, Inc., Irvine, CA
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1304. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.M. Liebmann, D.S. Greenfield, J. Piltz–Seymour, R. Ritch, T. Krupin, Low–pressure Glaucoma Study Group; Baseline Intraocular Pressure, Visual Function, and Disc Hemorrhage in the Low–Pressure Glaucoma Treatment Study . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1304.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the associations between baseline IOP, disc hemorrhage (DH) and visual field (VF) parameters in the Low–pressure Glaucoma Treatment Study (LoGTS). Methods: LoGTS is a randomized, double–masked trial to evaluate VF stability in patients randomized to topical twice–daily brimonidine tartrate 0.2% versus twice daily timolol maleate 0.5%. Low–pressure glaucoma (LPG) was defined as open angle glaucoma with a glaucomatous VF defect in at least one eye on Humphrey 24–2 full–threshold standard automated perimetry and all known IOP < 22 mmHg. Baseline measurements included untreated diurnal IOP curve (8 am, 10 am, 12 pm, and 4 pm), central corneal thickness (CCT) measurements, and stereophotography. Baseline disc photographs were assessed for DH by three masked observers. The relationship of ocular and non–ocular parameters in the DH and non–DH groups was assessed. Results: 380 eyes (190 patients) were enrolled (mean age 64.9 ±10.7 yrs) with an average VF mean deviation (MD) of –5.7 ± 4.1 dB. DH was present in one eye of 24 patients (12.6%) at baseline and was more common in women (p=0.02). DH and non–DH eyes were similar with respect to age (p=0.4), MD (p=0.3), PSD (p=0.6), peak IOP (p=0.7), diurnal fluctuation (peak IOP–trough IOP) (p=0.1), mean diurnal IOP (p=0.7), and CCT (p=0.1). There were no differences in the above parameters between the DH and non–DH eyes of the same patient (all p > 0.5). Conclusions: DH was common at the time of entry into the LoGTS study and was unrelated to IOP, CCT and the extent of visual field injury. A higher frequency of DH was observed in women.

Keywords: clinical (human) or epidemiologic studies: risk factor assessment • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×